Karolin Behringer

2.8k citations

52 papers · 1.6k indexed · h-index 21

Impact in

Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment
Reproductive Medicine top 2%
- Ovarian function and disorders

Papers in ⓘ

Pathology and Forensic Medicine 42
- Lymphoma Diagnosis and Treatment 42
Genetics 11
- Chronic Lymphocytic Leukemia Research 11

Co-authors: Volker Diehl (31 shared papers)Andreas Engert (31 shared papers)Peter Borchmann (31 shared papers)Michael Fuchs (24 shared papers)Teresa Halbsguth (11 shared papers)Thorsten Reineke (4 shared papers)L. Wildt (4 shared papers)Beate Klimm (5 shared papers)
Journals: Blood (16 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (5 papers)European Journal Of Haematology (3 papers)Frontiers in Oncology (2 papers)
Partner nations: Germany Switzerland Austria

In The Last Decade

Karolin Behringer

49 papers receiving 1.6k citations

Peers

Countries citing papers authored by Karolin Behringer

Since Specialization

Citations

This map shows the geographic impact of Karolin Behringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolin Behringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolin Behringer more than expected).

Fields of papers citing papers by Karolin Behringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolin Behringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolin Behringer. The network helps show where Karolin Behringer may publish in the future.

Co-authors

The 25 scholars most cited alongside Karolin Behringer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karolin Behringer Line = papers co-authored together Karolin Behringer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group Journal of Clinical Oncology ·Karolin Behringer, Kai Breuer, Thorsten Reineke, Michael May, Lucia Nogová, Beate Klimm, Tatiana Schmitz, L. Wildt, Volker Diehl, Andreas Engert	2005	218
2	Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials Journal of Clinical Oncology ·Karolin Behringer, Horst Mueller, Helen Goergen, Indra Thielen, Angelika Diana Eibl, Volker Stumpf, Carsten Wessels, Martin Wiehlpütz, Johannes Rosenbrock, Teresa Halbsguth, Katrin S. Reiners, Thomas Schober, Jörg H. Renno, Michael von Wolff, Katrin van der Ven, Marietta Kuehr, Michael Fuchs, Volker Diehl, Andreas Engert, Peter Borchmann	2012	164
3	No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group Annals of Oncology ·Karolin Behringer, L. Wildt, Horst Mueller, Verena Mattle, P. Ganitis, B. van den Hoonaard, Helmut W. Ott, Seline Hofer, Annette Pluetschow, Volker Diehl, Andreas Engert, Peter Borchmann	2010	113
4	Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group Blood ·Dennis A. Eichenauer, Indra Thielen, Heinz Haverkamp, Jeremy Franklin, Karolin Behringer, Teresa Halbsguth, Beate Klimm, Volker Diehl, Stephanie Sasse, Achim Rothe, Michael Fuchs, Boris Böll, Bastian von Tresckow, Peter Borchmann, Andreas Engert	2014	92
5	From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential Blood ·Daniel Ré, Roman K. Thomas, Karolin Behringer, Volker Diehl	2005	75
6	Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials Annals of Oncology ·Michal Sieniawski, Thorsten Reineke, Andreas Josting, Lucia Nogová, Karolin Behringer, Teresa Halbsguth, Michael Fuchs, Volker Diehl, Andreas Engert	2008	73
7	Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group The Lancet Oncology ·Dennis A. Eichenauer, Annette Plütschow, Stefanie Kreissl, Martin Sökler, Johannes C. Hellmuth, Julia Meißner, Stephan Mathas, Max S. Topp, Karolin Behringer, Wolfram Klapper, Georg Kuhnert, Markus Dietlein, Carsten Kobe, Michael Fuchs, Volker Diehl, Andreas Engert, Peter Borchmann	2017	70
8	Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group The Lancet Oncology ·Stefanie Kreissl, Horst Mueller, Helen Goergen, Axel Mayer, Corinne Brillant, Karolin Behringer, Teresa Halbsguth, Felicitas Hitz, Martin Soekler, Oluwatoyin Shonukan, Jens Ulrich Rueffer, Hans‐Henning Flechtner, Michael Fuchs, Volker Diehl, Andreas Engert, Peter Borchmann	2016	69
9	Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation Archives of Gynecology and Obstetrics ·Andreas N. Schüring, Tanja Fehm, Karolin Behringer, Maren Goeckenjan, Pauline Wimberger, Melanie Henes, Jörg Henes, Martin F. Fey, Michael von Wolff	2017	65
10	Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials Blood ·Boris Böll, Helen Goergen, Karolin Behringer, Paul J. Bröckelmann, Felicitas Hitz, Andrea Kerkhoff, Richard Greil, Bastian von Tresckow, Dennis A. Eichenauer, Carolin Bürkle, Sven Borchmann, Michael Fuchs, Volker Diehl, Andreas Engert, Peter Borchmann	2016	65
11	Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial Annals of Oncology ·Karolin Behringer, Indra Thielen, Horst Mueller, Helen Goergen, Angelika Diana Eibl, Johannes Rosenbrock, Teresa Halbsguth, Dennis A. Eichenauer, Michael Fuchs, Katrin S. Reiners, Joerg H. Renno, Katrin van der Ven, Marietta Kuehr, Michael von Wolff, Volker Diehl, Andreas Engert, Peter Borchmann	2012	63
12	Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration Journal of Clinical Oncology ·Karolin Behringer, Helen Goergen, Horst Müller, Indra Thielen, Corinne Brillant, Stefanie Kreissl, Teresa Halbsguth, Julia Meißner, Richard Greil, Peter Moosmann, Oluwatoyin Shonukan, Jens Ulrich Rueffer, Hans‐Henning Flechtner, Michael Fuchs, Volker Diehl, Andreas Engert, Peter Borchmann	2016	62
13	Role of Hematotoxicity and Sex in Patients With Hodgkin's Lymphoma: An Analysis From the German Hodgkin Study Group Journal of Clinical Oncology ·Beate Klimm, Thorsten Reineke, Heinz Haverkamp, Karolin Behringer, Hans Theodor Eich, Andreas Josting, Beate Pfistner, Volker Diehl, Andreas Engert	2005	58
14	Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group Annals of Oncology ·Karolin Behringer, Andreas Josting, Petra Schiller, Hans Theodor Eich, Henning Bredenfeld, Volker Diehl, Andreas Engert	2004	53
15	Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group Journal of Clinical Oncology ·Dennis A. Eichenauer, Annette Plütschow, Michael Fuchs, Bastian von Tresckow, Boris Böll, Karolin Behringer, Volker Diehl, Hans Theodor Eich, Peter Borchmann, Andreas Engert	2015	52
16	Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group Journal of Clinical Oncology ·Stefanie Kreissl, Horst Müller, Helen Goergen, Julia Meißner, Max S. Topp, Martin Sökler, Jana Marková, Jürg Bernhard, Richard Greil, Bastian von Tresckow, Karolin Behringer, Jens-Ulrich Rüffer, Hans‐Henning Flechtner, M. Möstl, Michael Fuchs, Andreas Engert, Volker Diehl, Peter Borchmann	2020	35
17	Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group Journal of Clinical Oncology ·Boris Böll, Helen Goergen, Nils Arndt, Julia Meißner, Stefan W. Krause, Roland Schnell, Bastian von Tresckow, Dennis A. Eichenauer, Stephanie Sasse, Michael Fuchs, Karolin Behringer, Beate Klimm, Ralph Naumann, Volker Diehl, Andreas Engert, Peter Borchmann	2013	35
18	Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group British Journal of Cancer ·(unknown), Karolin Behringer, Horst Müller, Helen Görgen, Hans‐Henning Flechtner, Corinne Brillant, Teresa Halbsguth, Indra Thielen, Dennis A. Eichenauer, Tilmann Schober, Hiltrud Nisters-Backes, Michael Fuchs, Andreas Engert, Peter Borchmann	2013	28
19	Female fertility after cytotoxic therapy – protection of ovarian function during chemotherapy of malignant and non‐malignant diseases European Journal Of Haematology ·Verena Mattle, Karolin Behringer, Andreas Engert, L. Wildt	2005	25
20	Targeted Beacopp Variants In Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Interim Results Of a Randomized Phase II Study Blood ·Peter Borchmann, Dennis A. Eichenauer, Annette Plütschow, Stefanie Kreissl, Michael Fuchs, Martin Soekler, Nicole Engel, Julia Meißner, Stephan Mathas, Karolin Behringer, Markus Dietlein, Carsten Kobe, Volker Diehl, Andreas Engert	2013	25

About Karolin Behringer

Karolin Behringer is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 52 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (42 papers), Lung Cancer Treatments and Mutations (20 papers), Chronic Lymphocytic Leukemia Research (11 papers), Childhood Cancer Survivors' Quality of Life (7 papers), Reproductive Biology and Fertility (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Cancer survivorship and care (5 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (828 citations), Reproductive Medicine (379 citations), Oncology (720 citations), Public Health, Environmental and Occupational Health (565 citations) and Neurology (259 citations). Karolin Behringer has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Volker Diehl, Andreas Engert, Peter Borchmann, Michael Fuchs, Teresa Halbsguth, Thorsten Reineke, L. Wildt, Beate Klimm, Dennis A. Eichenauer and Helen Goergen. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, European Journal Of Haematology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact